These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 35052635)
1. Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer's Disease Dementia. Araki W; Kametani F Antioxidants (Basel); 2022 Jan; 11(1):. PubMed ID: 35052635 [TBL] [Abstract][Full Text] [Related]
2. Aβ Oligomer Toxicity-Reducing Therapy for the Prevention of Alzheimer's Disease: Importance of the Nrf2 and PPARγ Pathways. Araki W Cells; 2023 May; 12(10):. PubMed ID: 37408220 [TBL] [Abstract][Full Text] [Related]
3. Natural products targeting amyloid-β oligomer neurotoxicity in Alzheimer's disease. Gonçalves PB; Sodero ACR; Cordeiro Y Eur J Med Chem; 2024 Jul; 276():116684. PubMed ID: 39032401 [TBL] [Abstract][Full Text] [Related]
4. Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer's Disease Model Mice. Taniguchi K; Yamamoto F; Arai T; Yang J; Sakai Y; Itoh M; Mamada N; Sekiguchi M; Yamada D; Saitoh A; Kametani F; Tamaoka A; Araki YM; Wada K; Mizusawa H; Araki W J Alzheimers Dis; 2019; 70(3):937-952. PubMed ID: 31227651 [TBL] [Abstract][Full Text] [Related]
5. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. Viola KL; Klein WL Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547 [TBL] [Abstract][Full Text] [Related]
6. Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease. Ding Y; Zhao J; Zhang X; Wang S; Viola KL; Chow FE; Zhang Y; Lippa C; Klein WL; Gong Y Front Neurol; 2019; 10():1140. PubMed ID: 31736856 [No Abstract] [Full Text] [Related]
7. ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer's Disease. Krafft GA; Jerecic J; Siemers E; Cline EN Front Neurosci; 2022; 16():848215. PubMed ID: 35557606 [TBL] [Abstract][Full Text] [Related]
9. Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease. Ma WH; Chen AF; Xie XY; Huang YS Neuropharmacology; 2021 Jun; 190():108342. PubMed ID: 33045243 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and Therapeutic Effects of Tocovid and Twendee-X on Aβ Oligomer-Induced Damage in the SH-SY5Y Cell Line. Hu X; Yamashita T; Yu H; Bian Z; Hu X; Feng T; Tadokoro K; Morihara R; Abe K Neurodegener Dis; 2021; 21(5-6):117-125. PubMed ID: 35272285 [TBL] [Abstract][Full Text] [Related]
11. Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons. Meng X; Song Q; Liu Z; Liu X; Wang Y; Liu J Front Aging Neurosci; 2024; 16():1400544. PubMed ID: 38808033 [TBL] [Abstract][Full Text] [Related]
12. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease. Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063 [TBL] [Abstract][Full Text] [Related]